HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Splenic Infarcts and Pulmonary Renal Syndrome in a Young Patient with Double-Positive Anti-GBM and ANCA-Associated Vasculitis.

Abstract
Double-positive disease, defined by double-seropositivity for serum anti-glomerular basement membrane (GBM) antibodies and anti-neutrophil cytoplasmic antibodies (ANCA) is a rare cause of pulmonary-renal syndrome. Here, we present an exceptional course of a 20-year-old male with seropositivity for anti-myeloperoxidase anti-neutrophil cytoplasmic antibodies and anti-GBM antibody, who presented first with renal impairment due to focal necrotizing crescentic glomerulonephritis. After receiving treatment, he presented two years later with a relapse manifesting with diffuse alveolar hemorrhage and multiple splenic infarcts. We discuss the clinical presentation patterns and treatment strategies of this entity.
AuthorsFares T Rajah, Ali A Alhabobi, Noura M Aloudah, Ayumun I Osman, Elwaleed A Elhassan
JournalSaudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia (Saudi J Kidney Dis Transpl) 2021 Jan-Feb Vol. 32 Issue 1 Pg. 240-244 ISSN: 1319-2442 [Print] Saudi Arabia
PMID34145139 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antibodies, Antineutrophil Cytoplasmic
  • Autoantibodies
  • antiglomerular basement membrane antibody
Topics
  • Antibodies, Antineutrophil Cytoplasmic (blood)
  • Autoantibodies (blood)
  • Glomerulonephritis (blood, complications)
  • Hemorrhage (blood, complications)
  • Humans
  • Lung Diseases (blood, complications)
  • Male
  • Splenic Infarction (blood, complications)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: